QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-leap-therapeutics-maintains-55-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Leap Therapeutics (NASDAQ:LPTX) with a Buy and maintains $...

 rodman--renshaw-initiates-coverage-on-leap-therapeutics-with-buy-rating-announces-price-target-of-8

Rodman & Renshaw analyst Tony Butler initiates coverage on Leap Therapeutics (NASDAQ:LPTX) with a Buy rating and announc...

 hc-wainwright--co-maintains-buy-on-leap-therapeutics-lowers-price-target-to-55

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Leap Therapeutics (NASDAQ:LPTX) with a Buy and lowers the p...

Core News & Articles

- SEC Filing

 baird-maintains-outperform-on-leap-therapeutics-lowers-price-target-to-9

Baird analyst Joel Beatty maintains Leap Therapeutics (NASDAQ:LPTX) with a Outperform and lowers the price target from $11 t...

 hc-wainwright--co-reiterates-buy-on-leap-therapeutics-maintains-7-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Leap Therapeutics (NASDAQ:LPTX) with a Buy and maintains $...

 leap-therapeutics-q4-eps-046-beats-055-estimate-cash-balance-of-706m

Leap Therapeutics (NASDAQ:LPTX) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0...

 leap-therapeutics-to-present-new-data-from-part-a-of-the-defiance-study-of-dkn-01-plus-bevacizumab-and-chemotherapy-in-colorectal-cancer-patients-at-the-2024-asco-gastrointestinal-cancers-symposium

Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics,...

 why-flj-group-shares-are-trading-higher-by-around-96-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of FLJ Group Limited (NASDAQ: FLJ) shares jumped during Friday’s session after the company announced it entered into a d...

 mizuho-maintains-buy-on-leap-therapeutics-lowers-price-target-to-12

Mizuho analyst Mara Goldstein maintains Leap Therapeutics (NASDAQ:LPTX) with a Buy and lowers the price target from $20 to $12.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION